Medtronic plc (MDT) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter h...
Medtronic plc (MDT) currently trades at a P/E ratio of 25.20 (historical range: 20.60–30.46, median: 26.00), placing it at the 32th percentile — below its historical average, P/S ratio of 3.28 (range: 2.68–3.90, 31th percentile — below its historical average), EV/EBITDA of 29.59 (range: 20.76–109.27, 38th percentile).
Medtronic plc appears undervalued relative to its historical range, with most valuation metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 25.20 | 20.60 | 26.00 | 30.46 | 32th | below its historical average |
| P/S Ratio | 3.28 | 2.68 | 3.44 | 3.90 | 31th | below its historical average |
| EV/EBITDA | 29.59 | 20.76 | 31.39 | 109.27 | 38th | below its historical average |
| FCF Yield | 0.03 | 0.00 | 0.03 | 0.05 | 64th | below its historical average |